文献速递肝病消化道肿瘤与早癌

非酒精性脂肪性肝炎是肝移植候选者中肝细胞癌增长最快的病因

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-06-14

该研究利用美国器官共享联合网络科学登记系统(2002-2016年)数据,分析158,347例成人肝移植候选者中肝细胞癌(HCC)的病因趋势。HCC比例从2002年的6.4%升至2016年的23.0%;非酒精性脂肪性肝炎(NASH)相关HCC比例增长7.7倍(从2.1%升至16.2%),且NASH患者HCC患病率增长11.8倍,增长趋势快于其他病因。结论认为NASH是美国肝移植候选者中HCC增长最快的病因。

要点

  • 肝移植候选者中HCC比例从2002年6.4%升至2016年23.0%(趋势P<.0001)。
  • NASH相关HCC比例增长7.7倍(从2.1%升至16.2%),增长趋势快于其他病因。
  • NASH患者HCC患病率增长11.8倍,高于CHB(6.0倍)、ALD(3.4倍)和CHC(2.3倍)。

核心结论

  • NASH是美国肝移植候选者中HCC增长最快的病因。

研究设计与样本

  • 基于美国器官共享联合网络科学登记系统(2002-2016年)的回顾性队列分析,纳入158,347例成人肝移植候选者。

主要发现

  • 158,347例成人肝移植候选者中,26,121例(16.5%)患有HCC;HCC比例从2002年的6.4%升至2016年的23.0%(趋势P<.0001)。
  • 研究期间慢性丙型肝炎(CHC)仍是HCC最常见病因(65%);CHC和酒精性肝病(ALD)相关HCC比例保持稳定(趋势P均>.10)。
  • 慢性乙型肝炎(CHB)相关HCC比例下降3.1倍(P<.0001),NASH相关HCC比例增长7.7倍(从2.1%升至16.2%;P<.0001)。
  • 自2002年以来,NASH患者HCC患病率增长11.8倍,CHB增长6.0倍,ALD增长3.4倍,CHC增长2.3倍(均P<.0001);NASH的增长趋势比任何其他病因都更陡峭(趋势回归模型P<.0001)。
  • 最终接受移植或等待期间死亡的HCC肝移植候选者比例在各病因间无差异(P>.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Although hepatitis B and C have been the main drivers of hepatocellular carcinoma (HCC), nonalcoholic steatohepatitis (NASH) has recently become an important cause of HCC. The aim of this study was to assess the causes of HCC among liver transplant (LT) candidates in the United States. METHODS: The Scientific Registry of Transplant Recipients (2002-2016) was used to estimate the trends in prevalence of HCC in LT candidates with the most common types of chronic liver disease: alcoholic liver disease (ALD), chronic hepatitis B (CHB), chronic hepatitis C, and NASH. RESULTS: 158,347 adult LT candidates were included. Of these, 26,121 (16.5%) had HCC; this proportion increased from 6.4% (2002) to 23.0% (2016) (trend P < .0001). Over the study period, CHC remained the most common etiology for HCC (65%). The proportions of HCC accounted for by CHC and ALD remained stable (both trend P > .10), the proportion of CHB decreased 3.1-fold (P < .0001), while the proportion of NASH in HCC increased 7.7-fold (from 2.1% to 16.2%; P < .0001). Furthermore, since 2002, the prevalence of HCC in LT candidates with NASH increased 11.8-fold, while this rate increased 6.0-fold in CHB, 3.4-fold in ALD, and 2.3-fold in CHC (all P < .0001); the increasing trend in NASH was steeper than that for any other etiology (P < .0001 in a trend regression model). The proportion of LT candidates with HCC who ultimately received a transplant or died while waiting did not differ between etiologies (P > .05). CONCLUSIONS: Nonalcoholic steatohepatitis is the most rapidly growing cause of HCC among US patients listed for liver transplantation.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Younossi Z, Stepanova M, Ong JP, et al. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin Gastroenterol Hepatol. 2018. PMID: 29908364. doi:10.1016/j.cgh.2018.05.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。